Method Article
This article describes a protocol for studying DNA-protein interactions using a streptavidin-based biolayer interferometry (BLI) system. It outlines the essential steps and considerations for utilizing either basic or advanced binding kinetics to determine the equilibrium binding affinity (KD) of the interaction.
Protein-DNA interactions underpin essential cellular processes. Understanding these interactions is critical for elucidating the molecular mechanisms of various pathways. Key factors such as the structure, sequence, and length of a DNA molecule can significantly influence protein binding. Bio-layer interferometry (BLI) is a label-free technique that measures binding kinetics between molecules, offering a straightforward and precise approach to quantitatively study protein-DNA interactions. A major advantage of BLI over traditional gel-based methods is its ability to provide real-time data on binding kinetics, enabling accurate measurement of the equilibrium dissociation constant (KD) for dynamic protein-DNA interactions. This article presents a basic protocol for determining the KD value of the interaction between a DNA replication protein, replication protein A (RPA), and a single-stranded DNA (ssDNA) substrate. RPA binds ssDNA with high affinity but must also be easily displaced to facilitate subsequent protein interactions within biological pathways. In the described BLI assay, biotinylated ssDNA is immobilized on a streptavidin-coated biosensor. The binding kinetics (association and dissociation) of RPA to the biosensor-bound DNA are then measured. The resulting data are analyzed to derive precise values for the association rate constant (ka), dissociation rate constant (kd), and equilibrium binding constant (KD) using system software.
Cellular proteins play a pivotal role in orchestrating the complex biological processes that occur within living organisms. The optimal functioning of these pathways is dependent on the interplay between proteins and other biomolecules inside the cell, including interactions with partner proteins and nucleic acids1. Thus, comprehending the intricacies of cellular processes necessitates a deep understanding of the dynamics of protein-nucleic acid interactions.
Traditionally, protein-nucleic acid interactions have been studied using electrophoretic mobility gel shift assays (EMSAs)2. In this assay, proteins are incubated with synthetic oligonucleotides (either DNA/RNA, containing specific lengths or sequences) for a short period, and the reaction is then electrophoresed on a native polyacrylamide (PAGE) gel3,4,5. To enable visualization of the protein-oligonucleotide interaction, the oligonucleotides are typically radioactively labeled with 32P or tagged with fluorescent molecules. If the protein interacts and binds the oligonucleotide, then the binding of the protein slows down the mobility of the nucleic acid within the gel6,7. Thus, this method is also called the gel shift or gel retardation assay. Though this method has been extensively used, there are a few limitations to consider while using this method to obtain KD values, including low resolution from either weak or dynamic binding, the requirement for a significantly high concentration of proteins, and more effort. Additionally, EMSAs are not real-time assays and, therefore, cannot accurately measure binding kinetics7,8.
Innovative techniques such as surface plasmon resonance (SPR) and biolayer interferometry (BLI) have emerged to overcome these limitations9,10,11,12. Both methods measure association/dissociation rate constants and affinity constants between molecules in a label-free manner. Since the protein is not required to be tagged, these techniques eliminate the risk of altering the properties of the protein or blocking the binding site. In SPR, polarized light interacts with a sensor (a metal conducting film, typically gold), generating an electron charge density wave called plasmon. This interaction diminishes the reflected beam's intensity and a detector measures the change in the specific angle, known as the resonance angle13. To study ligand (nucleic acid) - analyte (protein) interactions, the ligand is immobilized in one flow cell on the sensor chip, and the analyte is injected into the flow cell containing the immobilized ligand. On binding the analyte to the ligand, there is a detectable change in the refractive index near the sensor surface, thus allowing for the measurement of molecular interactions14,15,16.
Bio-Layer Interferometry (BLI) measures the pattern of light interference as light passes through an optical fiber with a biolayer, composed of a ligand (bait) and its binding partner (analyte), at the bottom surface of biosensor's tip. Light is transmitted through the tip and reflected at both ends of the biolayer due to the biolayer's properties. The biolayer thickness is proportional to the number of bound molecules that influence the pattern of the reflected light. By comparing the change of the curve of relative intensity vs. wavelength caused by interference between the reflected light from the reference interface and from the biolayer/buffer interface, the thickness change of the biolayer can be determined. When more molecule binds, a greater shift occurs, making BLI a powerful tool for studying biomolecular interactions in real time. The change in the interference pattern is measured and represented on a sensorgram as a spectral shift17,18 (Figure 1A). The nature of the binding interaction can be accurately determined by using appropriate controls, such as a setup lacking the ligand-varying concentrations of the binding partner19,20,21. Compared to SPR, BLI is cost-effective and user-friendly, rendering it accessible to a broad range of researchers. Additionally, samples used in BLI remain intact if there is no degradation or aggregation. This allows them to be possibly recovered and reused, thereby minimizing waste. The BLI instrument operates without the use of microfluidics, thereby eliminating the disadvantages of the fluidics system, such as the need for maintenance/care, clogging, or use of degassed buffers. It also minimizes the risk of contaminating the instrument due to unfiltered or crude protein samples.
In a BLI experiment, the biolayer is established by immobilizing the bait molecule on the biosensor. The biolayer of biosensors can interact with various tags, making it possible to study the interactions between molecules (including nucleic acids, proteins, antibodies, viruses, small molecules, etc.)22. Various capturing strategies, including biotin/streptavidin, 6X-His-tag/Ni-NTA, FLAG/anti-FLAG, GST/anti-GST, and antibody/anti-Fc, can be employed to establish this immobilization. Maintaining the structure and activity of the immobilized ligand is crucial when choosing the biosensor. The changes in the interference pattern are influenced by the amount of bound molecule as well as the matrix23. Protein-nucleic acid interactions are studied using biotinylated oligonucleotide probes that can be immobilized on streptavidin-coated biosensors. Protein samples expected to interact with the immobilized bait (oligonucleotide) are in contact with the oligonucleotide for a specific period in a binding buffer to measure association and subsequently switched to a blank binding buffer to measure dissociation. A schematic representation of analyte binding and corresponding changes in the binding curve is shown in Figure 1B. Additionally, protein-nucleic interactions can also be studied by a reversed immobilization route, in which the protein (bait) is captured on the biosensor and interacts with the nucleic acid (analyte).
Currently, multiple instruments are available commercially that operate on the principle of biolayer interferometry. A straightforward and cost-effective instrument is known as the Octet N1 system, which features a single channel for data throughput. It requires manual operation, consumes minimal sample volume (4 µL), and performs sample analysis at ambient temperatures9,23. This single-channel instrument can detect binding efficiencies of proteins larger than 10 kDa and measures affinities in the micromolar (µM) to nanomolar (nM) range11,12. Some instruments with 2, 8, 16, and 96 channels for automated data reading are also available and compatible with both 96 or 384 well formats19,20. Some of these instruments can also operate between 4 °C to 40 °C, detect biomolecules with molecular weight as low as 150 Da, and measure affinities within the millimolar to picomolar range19,21. While the described system is cost-effective, the pricier instruments with multiple channels offer high-throughput automatic processing. These advanced systems are commonly employed in characterizing and developing biological drug molecules9,23.
The current protocol describes the steps involved in measuring the binding parameters of replication protein A (RPA) to single-stranded DNA (ss-DNA) using the single-channel, manual biolayer interferometry system. RPA is a heterotrimeric, ssDNA-binding protein complex that plays a critical role in almost all aspects of DNA metabolism, including DNA replication, repair, and recombination24. Due to its high affinity to ssDNA (measured to be in the sub-nanomolar range), it can rapidly bind to ssDNA generated during various DNA transactions, protect it from nucleolytic degradation, and prevent impromptu binding of other downstream proteins. RPA also plays a critical role in preventing the formation of non-canonical secondary and tertiary structures, such as G-quadruplexes25. Human RPA is made up of three subunits: RPA70 (70 kDa), RPA32 (32 kDa), and RPA14 (14 kDa), also called RPA 1, RPA 2, and RPA 3, respectively24,26,27. These subunits house six oligonucleotide/oligosaccharide binding folds (OB-folds) labeled A to F. Among these, the DNA binding domains (DBDs) are on the RPA1 (DBD-A, DBD-B, DBD-C) and RPA2 (DBD-D) subunits28. It was first thought that depending on the DNA's length, RPA exhibits different binding modes where different DBDs were engaged to specific DNA lengths29. Data from recent structural and single molecule studies have helped refine these models to suggest that the binding of different DBDs of RPA is more dynamic than initially suggested30,31,32,33,34,35,36. This feature of the dynamic binding property is essential to the function of RPA because RPA should be able to bind tightly to the DNA substrate during certain DNA transactions; however, it should also be able to displace from the substrate to hand over the substrate to the next protein during the biological process. Using different biochemical techniques, the KD for RPA has been determined to be about 0.4 nM for a ss-(polydT)30 substrate, and 80 nM and 200 nM for ss-(polydA)257 and dG-(polydG)602 substrates respectively, as measured by fluorescence polarization anisotropy (FPA)37,38. RPA also shows about a 50-fold higher preference for binding to pyrimidine rich sequences compared to purines. Though different biochemical techniques have determined differing KD measurements for RPA, all measurements have been in the nanomolar range, suggesting RPA's high binding affinity for ssDNA. Employing total internal reflection fluorescence microscopy (TIRFM), it was discovered that based on the length of the DNA, RPA associated with at least two binding modes: one that was defined at fast dissociating (Kd, 680 pM) and a slow dissociating (Kd, 60 pM) complex33,39. Given its pivotal involvement in nearly all DNA metabolic pathways, there has been a keen interest in creating inhibitors that can hinder the interaction between RPA and single-stranded DNA (ssDNA). These chemical inhibitors are vital in disrupting the DNA damage response, rendering cancer cells more susceptible to DNA-damaging agents employed in clinical therapies. Utilizing the BLI assay allows for a precise quantitative evaluation of inhibitor efficacy in modulating RPA's binding function40,41.
BLI setup allows for distinct settings: basic and advanced kinetics. In basic kinetics mode, the assay comprises three primary stages: baseline establishment, association, and dissociation. However, before performing this assay, the biosensors need to be coated separately, using either the instrument or manually on the laboratory bench. Conversely, the advanced kinetics mode extends beyond the fundamental three steps, allowing for the incorporation of additional steps. These supplementary steps can serve various purposes, such as conditioning the biosensor to the buffer alterations or facilitating the detection of subsequent protein interactions. Advanced kinetics also allows stripping the biosensor of the analyte by a good regeneration method for potential reuse, provided the bait and the biosensor remain intact. Generally, advanced kinetics is used over basic kinetics when multiple steps are involved in the assay, or the assay needs to be performed in a more complex format.
This protocol outlines both methods using the same bait [3'Bio-ss-poly (dT)32] and analyte (RPA). A streptavidin-coated biosensor will be used to immobilize the bait, and KD measurements for the analyte will be obtained. This protocol describes a complete approach to perform a BLI assay using a single-channel instrument biolayer interferometry, covering biosensor-bait preparation, buffer considerations, and a step-by-step outline of the procedure.
Details of the reagents and the equipment used in the study are listed in the Table of Materials.
1. Preparation of bait, analyte, buffers and drop-holder cleaning
2. Basic kinetics
3. Setting up the instrument to run advanced kinetics
In BLI, white light is reflected from the interface of biolayer/buffer and the internal reference interface to the spectrometer. The resulting interference pattern is recorded, and the spectral shift is measured over a period of time and depicted as binding curves response in nm. A representative figure showing the biosensor tip with and without analyte binding and the corresponding spectral wavelength shift (nm) is shown in Figure 1. The binding curves correspond to the baselines, bait loading, and analyte association followed by analyte dissociation, as shown in Figure 2.
For this assay, BLI kinetics buffer was prepared as mentioned in the protocol and used for making 3'Bio-ss-poly (dT)32 stocks and the RPA protein stocks. It is recommended that the same buffer is used for all dilutions throughout the assay. The streptavidin biosensor was hydrated in BLI kinetics buffer at room temperature and then coated with 3'Bio-ss-poly (dT)32 substrate for basic kinetics. Four concentrations were evaluated to optimize the concentration of the substrate, along with a negative control (0 nM) (Figure 4). The sensorgram for 0 nM substrate will serve as a reference curve. For kinetics assay, it is recommended to use lower ligand/bait density that provides sufficient signal for accurate results17,18. In Figure 3, the steep pattern of the sensorgrams for 25 nM, 50 nM, and 100 nM substrate concentration may be due to measuring the responses in drop holder and tube, which have slightly different conditions (reflection patterns, distance from sensor surface to samples surface, etc.) for the biosensor. However, the loading step is not part of the binding kinetics data for fitting, and it does not impact the result. The biosensor was loaded with 12.5 nM biotinylated 3'Bio-ss-poly (dT)32 for 120 s and was utilized to obtain binding curves for five concentrations of RPA.
The sensorgram for RPA binding using basic kinetics is shown in Figure 4. The binding curve for 0nM protein will serve as the reference for subtraction. The BLI signal strength will increase with increasing concentrations of RPA until the immobilized DNA is saturated. In this assay, a single-loaded biosensor was utilized to study the binding kinetics of one concentration of RPA, after which the biosensor underwent a regeneration process and was reused for the next concentration. Regeneration was conducted by dipping the biosensor in 0.15 M phosphoric acid for 30 s, followed by neutralization in BLI buffer for 2 min.
The sensorgram for RPA binding using advanced kinetics is shown in Figure 5. Five biosensors were hydrated with BLI buffer for at least 10 min. Subsequently, each biosensor was loaded with a 12.5nM 3'Bio-ss-poly (dT)32 substrate for 120 s and was utilized to assess the binding kinetics of a singular concentration of RPA. Specifically, one biosensor is allocated for each concentration of the analyte.
After selecting the reference curves, the analyzed data will only depict sensorgrams for the protein concentrations (5 nM, 10 nM, 20 nM, and 40 nM). The reference curves will be used to negate the background signal before aligning the association and dissociation curves.
Figure 1: Schematic representations of biosensor binding and ligand interaction assay. (A) Diagram illustrating bait-coated biosensors in unbound and analyte-bound states. Binding of the analyte alters the biomolecular layer thickness on the biosensor surface, shifting the interference pattern of incident white light and producing a wavelength shift in the relative intensity/wavelength curve. Binding curves are generated by measuring spectral shifts (in nm) over time. SA: streptavidin, B: bait. (B) Diagram detailing ligand binding to biotinylated ssDNA bait loaded on streptavidin biosensors and corresponding changes in the binding curve measured through advanced kinetics. The assay involves several steps: [A] Establishing an initial baseline for the biosensors, [B] Immobilizing the 3′Bio-ss-poly(dT)32 bait on the biosensor, [C] Dipping biosensors into BLI buffer to assess bait loading levels, [D] Measuring analyte-bait association by immersing the biosensors in BLI buffer with the analyte, and [E] Measuring analyte dissociation by dipping the biosensor back into the BLI buffer. Please click here to view a larger version of this figure.
Figure 2: Slider positions for tube holder and drop holder with respect to the black arrowhead. Position A will have the tube holder under the biosensor. Position B will have the drop holder under the biosensor. Please click here to view a larger version of this figure.
Figure 3: Binding sensorgram for five concentrations (0 nM, 12.5 nM, 25 nM, 50 nM, 100 nM) of the 3'Bio-ss-poly (dT)32 bait on the streptavidin-coated biosensor. These sensorgrams represent raw data. Time 0-30 s represents baseline of the biosensor before loading, 30-150 s represents loading of bait, and 150-270 s represents the second baseline to ensure that some molecules are stably bound to the sensor. Please click here to view a larger version of this figure.
Figure 4: BLI sensorgram obtained with basic kinetics.Binding curves were obtained for four concentrations of RPA (5 nM, 10 nM, 20 nM, 40nM) bound to immobilized 3' Bio-ss-poly (dT)32 substrate. The black lines indicate fitting curves fitted with the 1:1 model. The purple line represents the sensorgram corresponding to each concentration. Time 0-150 s represents association, and 150-270 s represent dissociation. Please click here to view a larger version of this figure.
Figure 5: BLI sensorgram obtained with advanced kinetics. Binding curves for four concentrations of RPA (5 nM, 10 nM, 20 nM, 40 nM) bound to immobilized 3' Bio-ss-poly (dT)32 substrate. The black lines indicate fitting curves fitted with the 1:1 model. The purple line represents the sensorgram corresponding to each concentration. Time 0-300 s represents the association, and 300-450 s represents dissociation. Please click here to view a larger version of this figure.
(A) | |||
Step Type | Duration (s) | Position | |
1 | Baseline | 30 | Tube |
2 | Association | 120 | Drop |
3 | Dissociation | 120 | Tube |
(B) | |||
Step Type | Duration (s) | Position | |
1 | Initial Baseline | 30 | Tube |
2 | Loading | 120 | Drop |
3 | Baseline | 30 | Tube |
4 | Association | 120 | Drop |
5 | Dissociation | 120 | Tube |
Table 1: Run settings. The run settings for (A) basic kinetics and (B) advanced kinetics.Step durations and biosensor position for each step performed during the assay.
KD (nM) | KD Error (nM) | ka (1/Ms) | ka Error | kd (1/s) | kd Error | |
Basic Kinetics | 5.5 | 0.2 | 2.24E+05 | 1.58E+04 | 1.23E-03 | 7.19E-05 |
Advanced Kinetics | 6.8 | 0.2 | 1.18E+05 | 6.59E+03 | 8.11E-04 | 2.26E-05 |
Table 2: Analyzed data for basic and advanced kinetics.The analyzed data table shows the calculated values for KD, ka, and kd, as well as their respective errors.
Issue | Possible causes | Suggested solutions |
Inconsistent results | Improper instrument setup | Avoid placing the BLI instrument near a centrifuge or any other sort of vibrations that might interfere with readings. |
Abnormal Curves | Old/worn out internal light source. | Replace the internal light source/lamp. |
Avoid keeping the instrument in the direct sun. | ||
Old/expired biosensors | Ensure that the biosensors are kept sealed with silica gel packets and stored in dry cool and dark place. | |
Spike/Drops in data, unstable baseline, curves running lower than the baseline or baseline drift | Buffer Mismatch | Use freshly prepared buffers. |
Make all dilutions in the same buffer. | ||
Ensure that the same buffers are used throughout the assay. | ||
Bubbles in the sample | Centrifuge and pipette the sample carefully. | |
Filter the sample using a 0.22uM filter. | ||
Low signal | Uneven bait loading | Increase the duration of bait loading. |
Low/high concentration of bait | Optimize the bait concentrations by testing a range. | |
Skewed association curves | Non-specific analyte-biosensor interaction | Quench biosensor using an appropriate quencher, for example, biocytin. |
No change in the signal during dissociation | Tight analyte binding | Normal for analyte with slow off rate. Increase the duration of dissociation. |
Initial updrift during dissociation | Unstable bait-analyte interaction | Optimize the concentration of the bait and analyte. Adjust the duration of association. |
Maintain consistent buffer composition and prevent protein aggregation. | ||
Signal reduction following initial bait loading | Unstable bait/Bait dissociating from the biosensor. | Increase bait concentration and the duration of the dissociation step. |
Table 3: Guide to troubleshooting BLI assays. Possible issues and recommended solutions.
Supplementary Figure 1: Equipment software home page. The software screenshot shows the 'BASIC KINETICS' and 'ADVANCED KINETICS' options on the left panel. Please click here to download this figure.
Supplementary Figure 2: Software page for basic kinetics. The software screenshot shows the experiment details and duration setting for basic kinetics. Please click here to download this figure.
Supplementary Figure 3: Representative figure showing analyte binding on the bait immobilized biosensor after being regenerated multiple times. Each colored box represents one bait loading, analyte binding, followed by a regeneration event. Please click here to download this figure.
Supplementary Figure 4: Software page advanced kinetics. The software screenshot shows the experiment details and duration setting for advanced kinetics. Please click here to download this figure.
The ability to analyze the binding kinetics of any protein to its substrate using BLI provides the means to isolate and characterize the specific factors (such as sequence, structure, or length of a DNA) governing protein-DNA interactions within the cell19. The Octet N1 system, which relies on the principles of biolayer interferometry, allows for quantitative measurement of protein-protein and protein-nucleic acids interactions. Further, interactions between lipids, antibodies, and small molecules can be determined using this methodology42,43,44. Though fairly simple and straightforward to use, there are some nuances to consider when using the system to measure binding kinetics.
The current protocol measured the binding kinetics of the protein complex RPA to ssDNA - an interaction that has been assessed over the past many decades. Since RPA has multiple DNA binding domains, studies have also focused on the engagement of the different domains when exposed to different length ssDNA substrates. Modular binding studies showed that RPA engages an 8 nt ssDNA with low affinity and switches to high affinity binding when it interacts with a ssDNA ~28-30 nt in length33,39. Using the BLI assay, for a 32 nt poly dT substrate, the KD was calculated to be 5.5 nM using basic kinetics and 6.8 nM using advanced kinetics. Studies using other techniques such as EMSA, fluorescence polarization anisotropy (FPA), and single-molecule total internal reflection fluorescence microscopy (smTIRF) have all consistently detected the KD value within the low nanomolar range. However, there's an approximately 10-fold variation between different assays. This discrepancy highlights that while these studies provide valuable insights into binding affinities, they are not absolute values.
Assessing the binding curve obtained in Figure 4 and Figure 5, it is evident that the analyte (RPA) does not completely dissociate from the bait [3' Bio-ss-poly(dT)32] within a limited time. Given that RPA is known to dissociate from the substrate very slowly in the absence of competing proteins, it is not surprising that we don't observe significant dissociation in the assay. This is also consistent with our recent report wherein we had to use a 1000-fold excess of competing ssDNA to show RPA dissociation once bound to a 28 nt ssDNA substrate45. Weeramange et al. employed an alternative approach for analyzing binding kinetics characterized by slow dissociation, specifically utilizing steady-state fitting. This method allows for the determination of the dissociation constant (KD) based solely on the binding response at the equilibrium, corresponding to the plateau of the binding curve46. To achieve more accurate KD values, assays should be conducted using varying concentrations of the analyte, and the resulting data should be fit globally.
Given the sensitive nature of BLI kinetics, keeping the drop holder of the instrument contaminant-free is paramount. Before beginning the experiment, the drop holder is cleaned with 70% ethanol and water to remove surface contaminants. HCl (0.5 N) is then used for deep cleaning the drop holder. This is to ensure the removal of any dried-up droplets from previous experimental runs. Another wash with ethanol and water removes the HCl. Finally, the drop holder is washed with buffer and is ready for the experiment. The drop holder is washed with the buffer between runs to remove residual bait/protein. The four-step cleaning protocol involving ethanol, water, HCl, and buffer is not necessary between runs of the same experiment but is recommended before the start of a new experiment. This initial preparation is crucial as it ensures that all the equipment is free from contaminants, setting a solid foundation for reliable results.
Similarly, prior to setting up a BLI assay, it requires careful consideration of various parameters such as the choice of buffer, choice of biosensor, optimum bait loading concentration, and range of analyte concentration. While BLI is compatible with a wide range of buffers, it is crucial to ensure that each component is compatible and does not interfere with the measurements. An unstable baseline may be due to inappropriate buffer contents or precipitates in the buffer. Certain detergents may tend to cause abnormal protein binding, and thus, concentrations of these agents should be kept below critical micelle concentration in order to enhance their solubilization properties47,48. It is also important to maintain the same buffer throughout the experiment to establish the baseline curve and make bait and analyte dilutions. Buffer mismatch can lead to spikes or drops in the data curve and result in baseline drift due to changes in the biolayer's environment. It is recommended to start with a buffer that has previously worked for the protein of interest and use the same buffer throughout the assay for the hydration of biosensors and analyte and bait preparation. BLI kinetics can accommodate different buffers by establishing a baseline before each buffer usage. To prevent non-specific binding, BSA (range: 0.1-10 mg/mL) or Tween20 (range: 0.005%-0.05%) can be added to the buffer. However, it is essential to optimize their concentrations in the buffer19,21. Additionally, commercially available blocking buffers (e.g., Biocytin) can also be utilized.
The initiation of analysis of biomolecular interactions begins with the immobilization of the bait on the biosensor, highlighting the importance of selecting the appropriate biosensor. It is imperative to consider the sensitivity of these biosensors, their interactions with bait and analyte, potential non-specific binding, and their ability to maintain biological activity post-immobilization. Biotin/streptavidin interactions are most commonly utilized, but other biosensors, such as anti-FLAG/FLAG, anti-GST/GST, and anti-Fc/IgG probes, can also be used depending on the bait.
Appropriate controls pertaining to the assay are crucial for validating experimental results and accurately accessing the data. For most runs, these include a no bait and a no analyte control. Impurities in the analyte or sample aggregation can also alter the sensorgram and result in an unstable baseline. The concentration and the shape of the binding curve depend on the affinity of the analyte. Depending on the individual nature of the bait and the analyte, these timings can be adjusted and optimized. Additionally, non-specific binding can also be monitored by measuring the interaction between the analyte and the uncoated biosensor. In basic kinetics, a single-coated biosensor can be used to determine the binding curve for at least four different analyte concentrations with regeneration between different samples in our assays. With regeneration, the biosensor is stripped of the bound analyte and reused for the next analyte concentration. Advanced kinetics could also use one biosensor for several analyte concentrations with regeneration but allow the regeneration step to be included within the assay49,50.
Streptavidin biosensors employed in the experiment immobilize biotinylated bait through a non-covalent, nearly irreversible, and stable interaction. To obtain accurate data, optimizing the density of the immobilized ligand on the biosensor is necessary. A steep loading curve could suggest uneven loading. Over-saturation of the biosensor may lead to weak non-specific interactions at higher analyte concentrations or re-binding at lower analyte concentrations. Conversely, loading a low concentration of the bait may yield a lower response signal that is too low to detect. Typically, gradual loading is preferred over fast loading to ensure proper coating of the biosensor and prevention of assay artifacts17. Optimal results can be achieved by selecting the lowest concentration of the bait that produces a response signal distinguishable from the established baseline during the analyte association step. Generally, in label-free assays such as BLI or SPR, using the lowest concentration that still provides a sufficient signal yields more accurate results, as lower loading minimizes mass transport effects and other artifacts49,50,51.
Analyte concentrations range can be chosen based on their known KD value. The choice of analyte concentration to be used in the binding assay should range from 0.1-10 times the expected or estimated KD value. If the KD value is unknown, the concentration range can be assessed by experimentally acquiring BLI data at different analyte concentrations. Increasing the concentration of the ligands should result in a corresponding change in the binding curve. If there is no binding for a known sample, it could be due to several factors, such as degradation/immobilization of the bait, stripping of the bait, inability to interact due to aggregation of the ligand, or poor quality of biosensor tips. A guide to troubleshooting potential problems is listed in Table 3.
While BLI requires low equipment maintenance and has a user-friendly operation, it falls short in sensitivity compared to SPR. Additionally, it lacks strict control over evaporation17,49. When testing very tight binding (KD = below pM range), the assay usually requires long dissociation (for several hours), and evaporation could be an issue that introduces variation. Despite these challenges, real-time, label-free BLI analysis provides quick and accurate kinetics parameters, making it a robust quantitative assay. BLI is a diverse tool for research and analytical applications, making it a valuable resource for studying complex molecular interactions.
Authors have no conflict of interest to declare.
This work was funded by grants from the National Science Foundation (1929346) and the American Cancer Society (RSG-21-028-01). We would also like to thank members of the Balakrishnan laboratory for helpful discussions.
Name | Company | Catalog Number | Comments |
0.5 mL Micro Centrifuge Tubes | Globe Scientific | 111554A | |
96 Well Standard Black Microplate | Dot Scientific | 4ti-0223 | |
Biotinylated poly dT Oligonucleotide | IDT | ||
Bovine Serum Albumin (BSA) | Sigma-Aldrich | A2153-10G | |
Dithiothreitol (DTT) | Dot Scientific | DSD11000-10 | |
Ethylenediaminetetraacetic acid (EDTA) | Dot Scientific | DSE57020-500 | |
Hydrochloric Acid | Fisher Scientific | A144-500 | |
Kimtec Science Kimwipes | Kimtech | 34120 | |
Octet N1 Software | Sartorius | 1.4.0.13 | |
Octet SA Biosensor | Sartorius | 18-5019 | |
PBS pH 7.2 (10x) | Gibco | 1666711 | |
Personal Assay Octet N1 System | Sartorius | ||
Phosphoric Acid | Ward's Science | 470302-024 | |
Sodium Chloride (NaCl) | Dot Scientific | DSS23020-5000 | |
Tris Base | Dot Scientific | DST60040-5000 | |
Tween20 | Bio-Rad | 170-6531 |
Request permission to reuse the text or figures of this JoVE article
Request PermissionThis article has been published
Video Coming Soon
Copyright © 2025 MyJoVE Corporation. All rights reserved